Franklin Resources’s Tvardi Therapeutics TVRD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-315
| Closed | -$2.9K | – | 3043 |
|
|
2024
Q3 | $2.9K | Hold |
315
| – | – | ﹤0.01% | 2899 |
|
|
2024
Q2 | $2.92K | Hold |
315
| – | – | ﹤0.01% | 2847 |
|
|
2024
Q1 | $10.3K | Hold |
315
| – | – | ﹤0.01% | 2830 |
|
|
2023
Q4 | $8.42K | Hold |
315
| – | – | ﹤0.01% | 2606 |
|
|
2023
Q3 | $19K | Sell |
315
-416
| -57% | -$39K | ﹤0.01% | 2602 |
|
|
2023
Q2 | $74.4K | Buy |
731
+315
| +76% | +$43.4K | ﹤0.01% | 2574 |
|
|
2023
Q1 | $73.5K | Sell |
416
-9
| -2% | -$3.01K | ﹤0.01% | 2152 |
|
|
2022
Q4 | $164K | Hold |
425
| – | – | ﹤0.01% | 2043 |
|
|
2022
Q3 | $143K | Buy |
425
+4
| +1% | +$1.45K | ﹤0.01% | 2047 |
|
|
2022
Q2 | $139K | Sell |
421
-176
| -29% | -$61.7K | ﹤0.01% | 2099 |
|
|
2022
Q1 | $261K | Buy |
+597
| New | +$245K | ﹤0.01% | 2067 |
|
|
2020
Q2 | – | Sell |
-15,633
| Closed | -$7.43M | – | 1744 |
|
|
2020
Q1 | $7.43M | Hold |
15,633
| – | – | 0.01% | 851 |
|
|
2019
Q4 | $9.07M | Sell |
15,633
-328
| -2% | -$230K | ﹤0.01% | 911 |
|
|
2019
Q3 | $10.5M | Buy |
15,961
+3,447
| +28% | +$2.87M | 0.01% | 874 |
|
|
2019
Q2 | $9.69M | Hold |
12,514
| – | – | 0.01% | 897 |
|
|
2019
Q1 | $8.84M | Hold |
12,514
| – | – | ﹤0.01% | 911 |
|
|
2018
Q4 | $5.86M | Hold |
12,514
| – | – | ﹤0.01% | 971 |
|
|
2018
Q3 | $10.8M | Hold |
12,514
| – | – | 0.01% | 916 |
|
|
2018
Q2 | $8.63M | Hold |
12,514
| – | – | ﹤0.01% | 948 |
|
|
2018
Q1 | $5.58M | Hold |
12,514
| – | – | ﹤0.01% | 1029 |
|
|
2017
Q4 | $5.51M | Buy |
12,514
+445
| +4% | +$203K | ﹤0.01% | 1052 |
|
|
2017
Q3 | $5.95M | Hold |
12,069
| – | – | ﹤0.01% | 1038 |
|
|
2017
Q2 | $6.69M | Sell |
12,069
-4,384
| -27% | -$2.78M | ﹤0.01% | 1037 |
|
|
2017
Q1 | $10.9M | Hold |
16,453
| – | – | 0.01% | 945 |
|
|
2016
Q4 | $5.5M | Sell |
16,453
-530
| -3% | -$170K | ﹤0.01% | 1068 |
|
|
2016
Q3 | $5.11M | Hold |
16,983
| – | – | ﹤0.01% | 1102 |
|
|
2016
Q2 | $2.94M | Hold |
16,983
| – | – | ﹤0.01% | 1196 |
|
|
2016
Q1 | $3.8M | Hold |
16,983
| – | – | ﹤0.01% | 1150 |
|
|
2015
Q4 | $10.3M | Hold |
16,983
| – | – | 0.01% | 996 |
|
|
2015
Q3 | $8.74M | Hold |
16,983
| – | – | ﹤0.01% | 1047 |
|
|
2015
Q2 | $7.43M | Hold |
16,983
| – | – | ﹤0.01% | 1098 |
|
|
2015
Q1 | $6.14M | Hold |
16,983
| – | – | ﹤0.01% | 1145 |
|
|
2014
Q4 | $6.1M | Hold |
16,983
| – | – | ﹤0.01% | 1153 |
|
|
2014
Q3 | $5.13M | Sell |
16,983
-1,589
| -9% | -$652K | ﹤0.01% | 1180 |
|
|
2014
Q2 | $11.4M | Buy |
18,572
+569
| +3% | +$306K | 0.01% | 1036 |
|
|
2014
Q1 | $12.1M | Buy |
+18,003
| New | +$10.7M | 0.01% | 991 |
|
Other funds holding TVRD
FCM
SC
CRC
Franklin Resources's TVRD Position: Q4 2024 in Review
Franklin Resources sold out of Tvardi Therapeutics (TVRD) in Q4 2024, closing a stake of 315 shares — an estimated $2.9K sold.
Franklin Resources first reported a position in TVRD in Q1 2014 and held it in 36 quarters. The position peaked at $12.1M in Q1 2014. 43 funds tracked by Wall St. Rank hold TVRD as of Q4 2024.
- Franklin Resources reported no remaining Tvardi Therapeutics position as of Q4 2024 after selling out during the quarter.
- Franklin Resources sold 315 Tvardi Therapeutics shares in Q4 2024, an estimated $2.9K.
- Franklin Resources first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 36 quarters.
- Franklin Resources's Tvardi Therapeutics position peaked at $12.1M in Q1 2014.
- 43 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q4 2024.
Based on Franklin Resources's 13F filing for Q4 2024, filed 12 Feb 2025.